Tom Stargardt

ORCID: 0000-0003-3954-0955 · 1 paper in corpus · active 2011

Study types

  • article 1
article 2011
Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angiodema and Chronic Myleoid Leukaemia

Background: Market authorization does not guarantee patient access to any given drug. This is particularly true for costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of thi…